Literature DB >> 23333522

Synthetic lethality and cancer: cohesin and PARP at the replication fork.

Nigel J O'Neil1, Derek M van Pel, Philip Hieter.   

Abstract

Cohesins are mutated in a significant number of tumors of various types making them attractive targets for chemotherapeutic intervention. However, cohesins have a spectrum of cellular roles including sister chromatid cohesion, transcription, replication, and repair. Which of these roles are central to cancer biology and which roles can be exploited for therapeutic intervention? Genetic interaction networks in yeast have identified synthetic lethal interactions between mutations in cohesin and replication fork mediators. These interactions are conserved in worms and in human cells suggesting that inhibition of replication fork stability mediators such as poly (ADP-ribose) polymerase (PARP) could result in the specific killing of tumors with cohesin mutations. These findings also highlight the utility of genetic interaction networks in model organisms for the identification of clinically relevant interactions. Here, we review this type of approach, emphasizing the power of synthetic lethal interactions to reveal new avenues for developing cancer therapeutics.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23333522      PMCID: PMC3868440          DOI: 10.1016/j.tig.2012.12.004

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  69 in total

1.  Positive torsional strain causes the formation of a four-way junction at replication forks.

Authors:  L Postow; C Ullsperger; R W Keller; C Bustamante; A V Vologodskii; N R Cozzarelli
Journal:  J Biol Chem       Date:  2000-10-30       Impact factor: 5.157

2.  Sister chromatid cohesion is required for postreplicative double-strand break repair in Saccharomyces cerevisiae.

Authors:  C Sjögren; K Nasmyth
Journal:  Curr Biol       Date:  2001-06-26       Impact factor: 10.834

Review 3.  The structure and function of SMC and kleisin complexes.

Authors:  Kim Nasmyth; Christian H Haering
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

4.  Analysis of replication profiles reveals key role of RFC-Ctf18 in yeast replication stress response.

Authors:  Laure Crabbé; Aubin Thomas; Véronique Pantesco; John De Vos; Philippe Pasero; Armelle Lengronne
Journal:  Nat Struct Mol Biol       Date:  2010-10-24       Impact factor: 15.369

5.  GINS maintains association of Cdc45 with MCM in replisome progression complexes at eukaryotic DNA replication forks.

Authors:  Agnieszka Gambus; Richard C Jones; Alberto Sanchez-Diaz; Masato Kanemaki; Frederick van Deursen; Ricky D Edmondson; Karim Labib
Journal:  Nat Cell Biol       Date:  2006-03-12       Impact factor: 28.824

6.  Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers.

Authors:  Thomas D Barber; Kirk McManus; Karen W Y Yuen; Marcelo Reis; Giovanni Parmigiani; Dong Shen; Irene Barrett; Yasaman Nouhi; Forrest Spencer; Sanford Markowitz; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christoph Lengauer; Philip Hieter
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

7.  Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-6800, a poly(ADP-ribose) polymerase inhibitor.

Authors:  Sheila J Miknyoczki; Susan Jones-Bolin; Sonya Pritchard; Kathryn Hunter; Hugh Zhao; Weihua Wan; Mark Ator; Ronald Bihovsky; Robert Hudkins; Sankar Chatterjee; Andres Klein-Szanto; Craig Dionne; Bruce Ruggeri
Journal:  Mol Cancer Ther       Date:  2003-04       Impact factor: 6.261

8.  Are there any more ovarian tumor suppressor genes? A new perspective using ultra high-resolution copy number and loss of heterozygosity analysis.

Authors:  Kylie L Gorringe; Manasa Ramakrishna; Louise H Williams; Anita Sridhar; Samantha E Boyle; Jennifer L Bearfoot; Jason Li; Michael S Anglesio; Ian G Campbell
Journal:  Genes Chromosomes Cancer       Date:  2009-10       Impact factor: 5.006

9.  Systematic reduction of cohesin differentially affects chromosome segregation, condensation, and DNA repair.

Authors:  Jill M Heidinger-Pauli; Ozlem Mert; Carol Davenport; Vincent Guacci; Douglas Koshland
Journal:  Curr Biol       Date:  2010-05-06       Impact factor: 10.834

10.  NIPBL, encoding a homolog of fungal Scc2-type sister chromatid cohesion proteins and fly Nipped-B, is mutated in Cornelia de Lange syndrome.

Authors:  Emma T Tonkin; Tzu-Jou Wang; Steven Lisgo; Michael J Bamshad; Tom Strachan
Journal:  Nat Genet       Date:  2004-05-16       Impact factor: 38.330

View more
  18 in total

1.  Modeling DNA trapping of anticancer therapeutic targets using missense mutations identifies dominant synthetic lethal interactions.

Authors:  Akil Hamza; Leanne Amitzi; Lina Ma; Maureen R M Driessen; Nigel J O'Neil; Philip Hieter
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-06       Impact factor: 11.205

2.  Dynamic cohesin-mediated chromatin architecture controls epithelial-mesenchymal plasticity in cancer.

Authors:  Jiyeon Yun; Sang-Hyun Song; Hwang-Phill Kim; Sae-Won Han; Eugene C Yi; Tae-You Kim
Journal:  EMBO Rep       Date:  2016-07-27       Impact factor: 8.807

3.  Glioblastoma cells containing mutations in the cohesin component STAG2 are sensitive to PARP inhibition.

Authors:  Melanie L Bailey; Nigel J O'Neil; Derek M van Pel; David A Solomon; Todd Waldman; Philip Hieter
Journal:  Mol Cancer Ther       Date:  2013-12-19       Impact factor: 6.261

Review 4.  Functional interplay between cohesin and Smc5/6 complexes.

Authors:  Claudia Tapia-Alveal; Su-Jiun Lin; Matthew J O'Connell
Journal:  Chromosoma       Date:  2014-07-01       Impact factor: 4.316

5.  Abrupt transitions to tumor extinction: a phenotypic quasispecies model.

Authors:  Josep Sardanyés; Regina Martínez; Carles Simó; Ricard Solé
Journal:  J Math Biol       Date:  2016-10-06       Impact factor: 2.259

6.  Noise-induced bistability in the fate of cancer phenotypic quasispecies: a bit-strings approach.

Authors:  Josep Sardanyés; Tomás Alarcón
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

7.  Meeting Proceedings ICBS2016-Translating the Power of Chemical Biology to Clinical Advances.

Authors:  Yugo Kuriki; Toru Komatsu; Peter D Ycas; Sara K Coulup; Erick J Carlson; William C K Pomerantz
Journal:  ACS Chem Biol       Date:  2017-03-17       Impact factor: 5.100

Review 8.  A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapy.

Authors:  Chao Liu; Sriganesh Srihari; Kim-Anh Lê Cao; Georgia Chenevix-Trench; Peter T Simpson; Mark A Ragan; Kum Kum Khanna
Journal:  Nucleic Acids Res       Date:  2014-05-03       Impact factor: 16.971

Review 9.  Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition.

Authors:  M William Audeh
Journal:  Pharmgenomics Pers Med       Date:  2014-10-03

10.  A future of the model organism model.

Authors:  Jasper Rine
Journal:  Mol Biol Cell       Date:  2014-03       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.